Is KEMX or JNJ a better dividend investment in 2026?

KEMX currently yields 3.01% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between KEMX and JNJ?

KEMX has a forward dividend yield of 3.01% ($1.22/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.35 percentage points.

Home › Compare › KEMX vs JNJ

KEMX vs JNJ: Dividend Comparison 2026

KEMX yields 3.01% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KEMX wins by $4.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

KEMX

● Live price

3.01%

Share price

$40.39

Annual div

$1.22

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.2K

Annual income

$365.58

Full KEMX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — KEMX vs JNJ

📍 KEMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KEMX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KEMX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KEMX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KEMX

Annual income on $10K today (after 15% tax)

$255.94/yr

After 10yr DRIP, annual income (after tax)

$310.74/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $392.87/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KEMX + JNJ for your $10,000?

KEMX: 50%JNJ: 50%

100% JNJ50/50100% KEMX

Portfolio after 10yr

$22.1K

Annual income

$596.68/yr

Blended yield

2.70%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KEMX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KEMX buys

JNJ buys

No recent congressional trades found for KEMX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKEMXJNJ

Forward yield	3.01%	3.36% ✓
Annual dividend / share	$1.22	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$24.2K ✓	$20.0K
Annual income after 10y	$365.58	$827.78 ✓
Total dividends collected	$3.4K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: KEMX vs JNJ ($10,000, DRIP)

Year	KEMX Portfolio	KEMX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,001	$301.11	$10,676	$355.77	+$325.00 → KEMX
2	$12,081	$309.59	$11,407	$389.39	+$674.00 → KEMX
3	$13,244	$317.73	$12,198	$426.53	+$1.0K → KEMX
4	$14,497	$325.54	$13,056	$467.62	+$1.4K → KEMX
5	$15,845	$333.02	$13,987	$513.12	+$1.9K → KEMX
6	$17,294	$340.16	$14,998	$563.56	+$2.3K → KEMX
7	$18,851	$346.99	$16,098	$619.52	+$2.8K → KEMX
8	$20,525	$353.50	$17,295	$681.69	+$3.2K → KEMX
9	$22,321	$359.69	$18,599	$750.82	+$3.7K → KEMX
10	$24,249	$365.58	$20,022	$827.78	+$4.2K → KEMX

KEMX vs JNJ: Complete Analysis 2026

KEMX — Stock

Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float-adjusted market capitalization weighted index designed to measure the equity market performance of mid- and large-cap companies of emerging market countries, excluding China.

Full KEMX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this KEMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KEMX vs SCHD KEMX vs JEPI KEMX vs O KEMX vs KO KEMX vs MAIN KEMX vs ABBV KEMX vs MRK KEMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.